Blood serum microRNA biomarkers for oesophageal cancer

食管腺癌（OAC）是西方世界癌症死亡的第六大常见原因，并且发病率正在增加。在澳大利亚，大多数患者出现较晚，需要风险较大的治疗，治愈率较低。早期与晚期出现的个体之间的生存率有很大差异。早期发现癌症或癌前病变的更好方法将改善结果。我们的研究将开发一种血液检测方法，用于识别早期OAC患者，以便早期治疗。

Oesophageal adenocarcinoma (OAC) is the 6th commonest cause of cancer deaths in the Western World, and is increasing in incidence. In Australia most patients present late and require risky treatments with a low cure rate. There is a big difference in survival between individuals presenting early vs. late. Better methods to detect cancer early or detect pre-cancer will improve outcomes. Our research will develop a blood test for identifying individuals with early OAC to allow earlier treatment.